Bridgefront Capital’s Zevra Therapeutics ZVRA Stock Holding History
Bought
Maintained
Sold
Other funds holding ZVRA
Bridgefront Capital's ZVRA Position: Q3 2026 in Review
Bridgefront Capital opened a new position in Zevra Therapeutics (ZVRA) in Q3 2026: 34,436 shares worth $378K. The stake represents 0.09% of the portfolio and ranks #333 among its holdings.
173 funds tracked by Wall St. Rank hold ZVRA as of Q3 2026.
- Bridgefront Capital held 34,436 shares of Zevra Therapeutics worth $378K as of Q3 2026.
- Zevra Therapeutics was a new Bridgefront Capital position in Q3 2026.
- Zevra Therapeutics made up 0.09% of Bridgefront Capital's portfolio in Q3 2026, its #333 holding.
- 173 funds tracked by Wall St. Rank held Zevra Therapeutics as of Q3 2026.
Based on Bridgefront Capital's 13F filing for Q3 2026, filed 16 Nov 2026.